Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Other financing activities (2016 - 2025)

Historic Other financing activities for Milestone Scientific (MLSS) over the last 10 years, with Q3 2025 value amounting to $363082.0.

  • Milestone Scientific's Other financing activities fell 2499.51% to $363082.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $947160.0, marking a year-over-year increase of 4937.59%. This contributed to the annual value of $364953.0 for FY2024, which is 1258.61% down from last year.
  • Per Milestone Scientific's latest filing, its Other financing activities stood at $363082.0 for Q3 2025, which was down 2499.51% from $484078.0 recorded in Q3 2024.
  • Milestone Scientific's 5-year Other financing activities high stood at $484078.0 for Q3 2024, and its period low was $7.0 during Q1 2021.
  • Its 5-year average for Other financing activities is $128378.2, with a median of $50000.0 in 2023.
  • As far as peak fluctuations go, Milestone Scientific's Other financing activities plummeted by 9995.34% in 2021, and later skyrocketed by 86815.6% in 2024.
  • Milestone Scientific's Other financing activities (Quarter) stood at $77493.0 in 2021, then tumbled by 48.38% to $40000.0 in 2022, then skyrocketed by 150.0% to $100000.0 in 2023, then soared by 384.08% to $484078.0 in 2024, then dropped by 25.0% to $363082.0 in 2025.
  • Its Other financing activities stands at $363082.0 for Q3 2025, versus $484078.0 for Q3 2024 and $100000.0 for Q4 2023.